Correction to: Development and Application of a Physiologically Based Pharmacokinetic Model for Elagolix in the Adult and Adolescent Population.

IF 4.6 2区医学 Q1 PHARMACOLOGY & PHARMACY

Clinical Pharmacokinetics Pub Date : 2024-08-31 DOI:10.1007/s40262-024-01415-x

Xinghai Zhang, Xuanxuan Wang, Rui Li, Chenning Zhang, Jianmin Du, Hengli Zhao, Qing Wen

引用次数: 0

查看原文本刊更多论文

更正：开发和应用基于生理的艾拉戈利在成人和青少年人群中的药代动力学模型。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Pharmacokinetics 医学-药学

CiteScore

8.80

自引率

4.40%

发文量

审稿时长

6-12 weeks

期刊介绍： Clinical Pharmacokinetics promotes the continuing development of clinical pharmacokinetics and pharmacodynamics for the improvement of drug therapy, and for furthering postgraduate education in clinical pharmacology and therapeutics. Pharmacokinetics, the study of drug disposition in the body, is an integral part of drug development and rational use. Knowledge and application of pharmacokinetic principles leads to accelerated drug development, cost effective drug use and a reduced frequency of adverse effects and drug interactions.

文献相关原料

公司名称	产品信息	采购帮参考价格